|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| G01N 33/574 | |||
| A61P 35/00 | |||
| A61P 7/00 | |||
| A61P 17/00 | |||
| A61P 19/02 | |||
| A61P 29/00 | |||
| A61P 35/02 | |||
| A61P 37/00 | |||
| A61P 37/02 |
| (11) | Number of the document | 3284756 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17193089.4 |
| Date of filing the European patent application | 2006-10-12 | |
| (97) | Date of publication of the European application | 2018-02-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 725297 P | 2005-10-12 | US |
| (72) |
TESAR, Michael, DE
JÄGER, Ute, DE
|
| (73) |
MorphoSys AG,
Semmelweisstrasse 7, 82152 Planegg,
DE
|
| (54) | GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 |
| GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 |